An epigenome-focused CRISPR screen in enzalutamide-resistant prostate cancer identified a unique dependency against SWI/SNF complexes that is potentially mediated by an expansion of their binding regions.
- Bengul Gokbayrak
- Umut Berkay Altintas
- Nathan A. Lack